Bausch Health Companies Stock In The News

BHC Stock  USD 7.46  0.01  0.13%   
Our overall analysis of Bausch Health's news coverage and content from conventional and social sources shows investors' bearish mood towards Bausch Health Companies. The specific impact of Bausch Health news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Bausch Health's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Bausch Health headlines in addition to utilizing other, more conventional financial analysis modules. Check out Bausch Health Backtesting and Bausch Health Hype Analysis.

Bausch Health Today Top News and Investor Outlook

Yahoo News
Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025
https://finance.yahoo.com/news/bausch-health-announce-fourth-quarter-120000833.html
 Bullish
Yahoo News
Market Chatter: Bausch Health Swaps Out Advisers After Years of Debt, Sale Talks
https://finance.yahoo.com/news/market-chatter-bausch-health-swaps-222341699.html
 Neutral
Yahoo News
Bausch Health Swaps Out Advisers After Years of Debt, Sale Talks
https://finance.yahoo.com/news/bausch-health-swaps-advisers-years-184911243.html
 Neutral
Yahoo News
Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
https://finance.yahoo.com/news/ozempic-xtandi-among-next-15-132048211.html
 Neutral
Yahoo News
Bausch Health Notes Xifaxan 550 mg Selected For Medicare 2nd Round Negotiations
https://finance.yahoo.com/news/bausch-health-notes-xifaxan-550-152725266.html
 Neutral
Yahoo News
Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program
https://finance.yahoo.com/news/bausch-health-statement-selection-xifaxan-142500457.html
 Neutral
Yahoo News
Wall Street Analysts See a 25.5% Upside in Bausch (BHC): Can the Stock Really Move This High?
https://finance.yahoo.com/news/wall-street-analysts-see-25-145515618.html
 Bullish
Yahoo News
Strength Seen in BridgeBio Pharma (BBIO): Can Its 16.0% Jump Turn into More Strength?
https://finance.yahoo.com/news/strength-seen-bridgebio-pharma-bbio-095900333.html
 Bullish
Yahoo News
Bausch + Lomb Acquires Whitecap Biosciences, Financial Details Not Disclosed
https://finance.yahoo.com/news/bausch-lomb-acquires-whitecap-biosciences-130608104.html
 Neutral
Yahoo News
Is Bausch + Lomb (BLCO) the Best Medical Stock to Buy Under $20?
https://finance.yahoo.com/news/bausch-lomb-blco-best-medical-143055773.html
 Bullish

Bausch Health Companies Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Bausch and other traded companies coverage with news coverage. We help investors stay connected with Bausch headlines for the 30th of January to make an informed investment decision based on correlating the impacts of news items on Bausch Stock performance. Please note that trading solely based on the Bausch Health Companies hype is not for everyone as timely availability and quick action are needed to avoid losses.
Bausch Health's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Bausch Health Companies investors visualize upcoming and past events in order to time the market based on Bausch Health Companies noise-free hype analysis.
Bausch Health stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Bausch earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Bausch Health that are available to investors today. That information is available publicly through Bausch media outlets and privately through word of mouth or via Bausch internal channels. However, regardless of the origin, that massive amount of Bausch data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bausch Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bausch Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bausch Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bausch Health alpha.

Bausch Largest EPS Surprises

Earnings surprises can significantly impact Bausch Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
1997-02-27
1996-12-310.060.070.0116 
2001-04-26
2001-03-310.180.20.0211 
1996-07-17
1996-06-300.040.060.0250 
1996-04-17
1996-03-310.030.050.0266 
2004-08-04
2004-06-300.240.280.0416 
2004-04-29
2004-03-310.130.180.0538 
View All Earnings Estimates

Bausch Health Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Bausch Health Companies Stock. Current markets are strongly bullish. About 75% of major world exchanges and indexes are currently up. See today's market update for more information.
Macroaxis News
28th of January 2025
Disposition of 765 shares by Seana Carson of Bausch Health at 9.16 subject to Rule 16b-3
at MacroaxisInsider 
Gurufocus Stories at Macroaxis
17th of January 2025
Bausch Health Companies Inc Announces XIFAXANs Selection for Medicare Negotiation Program
at gurufocus.com 
news
16th of January 2025
Sanders Morris Harris LLC Buys 4,000 Shares of Bausch Health Companies Inc.
at thelincolnianonline.com 
Macroaxis News
31st of December 2024
Acquisition by Brett Icahn of 4109 shares of Bausch Health at 8.06 subject to Rule 16b-3
at MacroaxisInsider 
Google News at Macroaxis
20th of December 2024
Zacks Research Has Optimistic Outlook of BHC Q3 Earnings - MarketBeat
at news.google.com 
Gurufocus Stories at Macroaxis
12th of December 2024
Bausch Health Companies Inc Responds to Potential Sale Rumors
at gurufocus.com 
Google News at Macroaxis
5th of December 2024
Readystate Asset Management LP Grows Position in Bausch Health Companies Inc. - MarketBeat
at news.google.com 
seekingalpha News
2nd of December 2024
Disposition of 440 shares by Seana Carson of Bausch Health at 8.35 subject to Rule 16b-3
at seekingalpha.com 
Simply Wall St News at Macroaxis
29th of November 2024
Bausch Health Companies Inc. is largely controlled by institutional shareholders who own 5...
at simplywall.st 
zacks News
4th of November 2024
Why Bausch Health is a Top Momentum Stock for the Long-Term
at zacks.com 

Bausch Health Investors Sentiment

The influence of Bausch Health's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Bausch. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Bausch Health's public news can be used to forecast risks associated with an investment in Bausch. The trend in average sentiment can be used to explain how an investor holding Bausch can time the market purely based on public headlines and social activities around Bausch Health Companies. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Bausch Health's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bausch Health's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Bausch Health's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Bausch Health.

Bausch Health Implied Volatility

    
  0.86  
Bausch Health's implied volatility exposes the market's sentiment of Bausch Health Companies stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bausch Health's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bausch Health stock will not fluctuate a lot when Bausch Health's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bausch Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bausch Health's short interest history, or implied volatility extrapolated from Bausch Health options trading.
When determining whether Bausch Health Companies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bausch Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bausch Health Companies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bausch Health Companies Stock:
Check out Bausch Health Backtesting and Bausch Health Hype Analysis.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.61)
Earnings Share
(0.48)
Revenue Per Share
25.794
Quarterly Revenue Growth
0.122
Return On Assets
0.0415
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bausch Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.